Health Care: Drugs

Illumina Inc (ILMN: NASDAQ)

$138.91 n/a | n/a%
06/24/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 138.91
52 Week High 242.37
52 Week Low 127.10
Avg. Daily Vol. (Mil) 1.42
Beta (3 year) 0.64
Share Related Items
Mkt Cap (Mil) 20,447.55
Shares Out (Mil) 147.20
Float (Mil) 128.11
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.60
Current Ratio 4.30
LT Debt/ Equity 0.51
Total Debt / Equity 0.51
Valuation Ratios
Price Earnings 49.90
Price/Sales 9.08
Price/Book 10.27
Price/Cash Flow 35.60
Per Share Data
Earnings 2.78
Sales 15.31
Book Value 13.53
Cash Flow 3.90
Business Summary
Illumina Inc provides sequencing-and array-based solutions for genetic analysis. Its products enabled researchers to explore DNA, helping them create the first map of gene variations associated with health, disease, and drug response.
General Information
5200 Illumina Way
San Diego, CA 92122
Industry : Drugs
Sector: Health Care
Employees: 4600
CEO: Jay T. Flatley
Short Interest
Current Month (Mil) 6.89
Previous Month (Mil) 7.06
Short Interest Ratio (Days) 8.60
Management Effectiveness
Return on Equity 20.50
Return on Assets 10.80
Return on Investments 13.50
Gross Margin 77.10
EBIT Margin 24.90
Profit Margin 18.10

Portfolios with ILMN

Latest ILMN Headlines from TheStreet

More Financial News for ILMN

Press Releases for ILMN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter